Parkwood LLC’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Parkwood LLC’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-101,900	Closed	-$1.45M	–	156
2018 Q1	$1.45M	Hold	101,900	–	–	0.21%	58
2017 Q4	$1.49M	Hold	101,900	–	–	0.2%	68
2017 Q3	$1.29M	Hold	101,900	–	–	0.19%	73
2017 Q2	$1.21M	Hold	101,900	–	–	0.18%	106
2017 Q1	$1.51M	Hold	101,900	–	–	0.21%	94
2016 Q4	$1.65M	Hold	101,900	–	–	0.25%	94
2016 Q3	$1.85M	Hold	101,900	–	–	0.27%	82
2016 Q2	$1.68M	Hold	101,900	–	–	0.28%	71
2016 Q1	$1.69M	Hold	101,900	–	–	0.29%	68
2015 Q4	$2.21M	Buy	101,900 +69,900	+218%	+$1.36M	0.35%	51
2015 Q3	$634K	Hold	32,000	–	–	0.1%	110
2015 Q2	$1.11M	Buy	+32,000	New	+$977K	0.16%	68

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Scopia Capital Management New York $112M AUM 48.41% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Parkwood LLC's HZNP Position: Q2 2018 in Review

Parkwood LLC sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q2 2018, closing a stake of 101,900 shares — an estimated $1.45M sold.

Parkwood LLC first reported a position in HZNP in Q2 2015 and held it in 12 quarters. The position peaked at $2.21M in Q4 2015. 204 funds tracked by Wall St. Rank hold HZNP as of Q2 2018.

Parkwood LLC reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q2 2018 after selling out during the quarter.
Parkwood LLC sold 101,900 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q2 2018, an estimated $1.45M.
Parkwood LLC first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2015 and held it in 12 quarters.
Parkwood LLC's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $2.21M in Q4 2015.
204 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q2 2018.

Based on Parkwood LLC's 13F filing for Q2 2018, filed 9 Aug 2018.